Your distribution partner 
for the healthcare industry

› High quality products 
› Technical support
› European sales structure

Our Portfolio

APIs

Active ingredients for various medical uses as well as regulatory consulting and customized sourcing services.

Excipients

Excipients for topical and oral applications like skin protectants, carriers, rheological modifiers, sweeteners, humectants, fillers, binders and disintegrants.

Nutraceuticals

Natural extracts, minerals, vitamins, proteins and various excipients for Nutraceuticals

Excipients for topical and oral applications like skin protectants, carriers, rheological modifiers, sweeteners, humectants, fillers, binders and disintegrants.

Our Portfolio

Active
pharmaceutical
ingredients

Excipients

Nutraceuticals

Our Services

Offer

› Product
portfolio
› REACH & GDP
compliance

Excipients

› Technical

› Regulatory

› Formulation development

› Laboratory

Relations

› Long-term partnerships

› Global sourcing network

› Transparency

Spotlight

GDP compliant

News and Press

Our partners

Laboratory, formulation and project support

Our Portfolio

APIs

Active ingredients for various medical uses as well as regulatory consulting and customized sourcing services.

Excipients

Excipients for topical and oral applications like skin protectants, carriers, rheological modifiers, sweeteners, humectants, fillers, binders and disintegrants.

Nutraceuticals

Natural extracts, minerals, vitamins, proteins and various excipients for Nutraceuticals

Our Services

Offer

› Selected product
portfolio
› REACH compliance
› GDP compliance

Support

› Technical
› Regulatory
› Formulation
development
› Laboratory

Relations

› Long-term
partnerships
› Global sourcing
network
› Transparency

Spotlight

Laboratory
Services

› Formulations
› Product testing
› Project support
› Regulation advice

News and Press

GDP
compliant

Our distribution processes
are set up in compliance
with applicable Good
Distribution Practice
requirements.

Our partners

Our Services

Offer

  • Selected product portfolio
  • REACH compliance
  • GDP compliance

Support

  • Technical
  • Regulatory
  • Formulation development
  • Laboratory

Relations

  • Long-term partnerships with customers and suppliers
  • Global sourcing network
  • Transparency

Spotlight

Laboratory Services

  • Formulations
  • Product testing
  • Project support
  • Regulation advice

News & Press

Learn More

Our partners

Learn More

GDP compliant

Learn More

Technical product support

Global sourcing network

Long-term relationships with suppliers and customers

REACH & GDP compliance

Go to article: Home | Under the microscopeGo to article: In this issueGo to article: SHL Medical Company InsightGo to article: SHL MedicalGo to article: ContentsGo to article: MimotopesGo to article: NewsGo to article: VEGA AustraliaGo to article: Covid-19 executive briefing by GlobalDataGo to article: WipotecGo to article: Nasal spray vaccine for Covid-19Go to article: Datwyler Company Insight Go to article: DatwylerGo to article: Covid-19 clinical trials continue to rise in BrazilGo to article: BiogazelleGo to article: AstraZeneca’s Phase I / II Covid-19 vaccine trial Go to article: SwiftpakGo to article: MTPA resumes screening and enrolment for global Phase III clinical trial of MT-1Go to article: Biesterfeld Go to article: The pharma industry briefingGo to article: From antitoxins to Covid-19 drugs: charting the history of antibody drugsGo to article: Quality control: pharma manufacturing inspections explainedGo to article: Molnár-Institute Company InsightGo to article: Molnar-InstituteGo to article: Oxytocin: the therapeutic potential of the ‘love hormone’Go to article: AI-enabled risk detection in pharma manufacturingGo to article: Dr. Paul LohmannGo to article: Addressing the long-term effects of Covid-19Go to article: Eyes on the prize: the latest in retinitis pigmentosa gene therapiesGo to article: HOF Sonderanlagenbau Company Insight Go to article: HOF SonderanlagenbauGo to article: Breaking the taboo: disrupting the fertility sectorGo to article: Neutralising the gluten threat: are we on the cusp of a coeliac disease breakthrough? Go to article: Nolato Company Insight Go to article: NolatoGo to article: Pharmacovigilance case intake: why the hesitation to automate?Go to article: Deals in brief powered by GlobalDataGo to article: The key list powered by GlobalDataGo to article: Zenatek Go to article: Global markets and indices powered by GlobalDataGo to article: Macro-economic indicators (1 of 2) powered by GlobalDataGo to article: Macro-economic indicators (2 of 2) powered by GlobalDataGo to article: EventsGo to article: Next issue